IP Library › Patent Application 63296770
Patent Application Provisional Small
App. No. 63/296,770 · Confirmation No. 3894

GAMMA DELTA T-CELL-TARGETED MODIFIED IL-2 POLYPEPTIDES AND USES THEREOF

Applicant: Inhibrx, Inc.
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2022-01-12 APP.FILE.REC Filing Receipt 3 View
2022-01-05 ADS Application Data Sheet 10 View
2022-01-05 DRW.NONBW Drawings-other than black and white line drawings 13 View
2022-01-05 SPEC Specification 62 View
2022-01-05 CLM Claims 7 View
2022-01-05 ABST Abstract 1 View
2022-01-05 WFEE Fee Worksheet (SB06) 2 View
2022-01-05 N417 Electronic Filing System Acknowledgment Receipt 3 View
2022-01-05 SCORE Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) 1 View
2022-01-05 DRW.SUPP Drawings-black and white line and/or other drawings — View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
63/296,770
Filed
2022-01-05